It undertakes the development of cell therapies based on autologous adipose-derived regenerative cells for the treatment of cardiovascular disease as well as for the repair soft tissue defects. Cytori has three key product lines, namely, the Celution family, which includes the first and only broadly available device that provides clinical grade adipose derived autologous stem and regenerative cells for re-injection into the patient at the point of care; and the StemSource family for use in laboratory research and stem cell banking.
http://ift.tt/1yZcr3o
http://ift.tt/1yZcr3o
No comments:
Post a Comment